TCL Archive Higher Response For Gleevec In Trial; CML Patients Allowed To Switch By Cancer History Project January 25, 2002
TCL Archive Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant. By Cancer History Project January 25, 2002
TCL Archive Susan Sieber, Former NCI Communications Chief, Dead. By Cancer History Project January 25, 2002
TCL Archive Late Effects In Breast Cancer Treatment Found In Study By Cancer History Project January 25, 2002
TCL Archive Clinical Trials Approved By NCI Last Month Are Listed By Cancer History Project January 25, 2002
TCL Archive Andrew von Eschenbach Sworn In As NCI Director. By Cancer History Project January 25, 2002
TCL Archive Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch. By Cancer History Project January 25, 2002
TCL Archive Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash. By Cancer History Project January 25, 2002
Article Latino oncology leaders discuss representation in clinical trials, translational research, and health care By Cancer History Project